PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

Unlocking the Opportunities Hidden in Healthcare Data

By now, everyone’s heard about the explosion of data in healthcare, but few realize just how massive this space has become. As the world’s gone digital, with every pa...
Continue Reading →
Regional News

Key vaccine leaders departing FDA as COVID-19 booster questions linger

Two key vaccine leaders will leave the FDA this fall, just as the agency faces key decisions over COVID-19 booster shots and as variants take a bite out of the shots’...
Continue Reading →
Regional News

FDA approval of Pfizer’s COVID-19 vaccine spurs American confidence: Harris Poll

Last week's FDA approval of Pfizer’s Comirnaty vaccine boosted consumer confidence among both vaccinated and unvaccinated people. A Harris Poll survey over the weeke...
Continue Reading →
Regional News

Three Ways to Optimize Promotions and Drive Dynamic Deployment

You don’t need me to tell you: It’s harder than ever for commercial teams to get access to healthcare providers (HCPs) for face-to-face promotion. That was the case b...
Continue Reading →
Regional News

Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more

With a self-proclaimed “Super Plant” already on the way in South Korea, Samsung Biologics CEO John Rim said in January that the CDMO’s expansion push was just getting...
Continue Reading →
Regional News

Novartis’ Kymriah flops in earlier lymphoma use, where Gilead, Bristol Myers CAR-T rivals succeeded

Novartis’ Kymriah is losing its shot at a key market expansion opportunity in second-line lymphoma, where CAR-T rivals from Gilead Sciences and Bristol Myers Squibb r...
Continue Reading →
Regional News

Capturing The True Value of Patient Data By Aligning Stakeholder Incentives

Life science organizations and academic medical centers have an opportunity to advance scientific research by leveraging data, but there is one major roadblock: stake...
Continue Reading →
Regional News

Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users

Biohaven Pharmaceuticals is flexing its migraine share leapfrog over powerhouse AbbVie—thanks to Nurtec ODT's dual acute-plus-prevention nod and an aggressive digital...
Continue Reading →
Regional News

Manufacturing issues force delay for PolarityTE’s skin repair hopeful

Manufacturing issues are common with regenerative medicines. And so it goes for PolarityTE's investigational new drug submission for SkinTE. On Tuesday the Salt Lake...
Continue Reading →
Regional News

Organon shares jump as Merck’s new women’s health spinoff posts strong start for biosims, infertility drugs

It’s been a mere two months since Merck’s women’s health spinoff Organon set off to chart its own path as an independent company. That hasn’t been an easy feat amid a...
Continue Reading →
Quotient